Human proinsulin. Does it improve the treatment of type I diabetics?
Landgraf-Leurs
M M
MM
Medizinische Klinik Innenstadt, Universität München, Germany.
Hörmann
R
R
Loy
A
A
König
A
A
Kammerer
S
S
Landgraf
R
R
D000328:Adult; D001786:Blood Glucose / Q000378:metabolism; D001798:Blood Proteins / Q000378:metabolism; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005260:Female; D006023:Glycoproteins; D006728:Hormones / Q000097:blood; D006801:Humans; D007328:Insulin / Q000627:therapeutic use*; D007700:Kinetics; D008297:Male; D011384:Proinsulin / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use; D000093422:Glycated Serum Proteins
D001786:Blood Glucose; D001798:Blood Proteins; D006023:Glycoproteins; D006728:Hormones; D007328:Insulin; D011994:Recombinant Proteins; D011384:Proinsulin; D000093422:Glycated Serum Proteins